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Aromatase cytochrome P450arom (cyp19) is the only enzyme that has the ability
to convert androgens into estrogens. Estrogens, which are produced locally in the
vertebrate brain play many fundamental roles in neuroendocrine functions, reproductive
functions, socio-sexual behaviors, and neurogenesis. Radial glial cells (RGCs) are
neuronal progenitor cells that are abundant in fish brains and are the exclusive site
of aromatase B expression and neuroestrogen synthesis. Using a novel in vitro RGC
culture preparation we studied the regulation of aromatase B by 17β-estradiol (E2)
and dopamine (DA). We have established that activation of the dopamine D1 receptor
(D1R) by SKF 38393 up-regulates aromatase B gene expression most likely through
the phosphorylation of cyclic AMP response element binding protein (CREB). This
up-regulation can be enhanced by low concentration of E2 (100 nM) through increasing
the expression of D1R and the level of p-CREB protein. However, a high concentration
of E2 (1µM) and D1R agonist together failed to up-regulate aromatase B, potentially
due to attenuation of esr2b expression and p-CREB levels. Furthermore, we found the
up-regulation of aromatase B by E2 and DA both requires the involvement of esr1 and
esr2a. The combined effect of E2 and DA agonist indicates that aromatase B in the adult
teleost brain is under tight control by both steroids and neurotransmitters to precisely
regulate neuroestrogen levels.
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INTRODUCTION
Aromatase cytochrome P450arom (cyp19) is the only enzyme performing the conversion of
androgens into estrogens (Lephart, 1996; Garcia-Segura et al., 2003). In all species of vertebrates,
including mammals, birds, and teleost fish, aromatase expression can be found in the brain in
addition to testes and ovaries (Balthazart and Ball, 1998; Forlano et al., 2001). The distribution
of aromatase varies between species and regions in the central nervous system (CNS), which has
been detected at multiple levels, including mRNA, protein, and enzyme activity (Lephart, 1996;
Balthazart and Ball, 1998; Forlano et al., 2006; Garcia-Segura, 2008; Azcoitia et al., 2011). In
mammals, aromatase is expressed in both neuronal and glial cell bodies, processes and synaptic
terminals of specific areas, especially the pial surface and ventricular surface in the brain under
normal conditions (Martínez-Cerdeno et al., 2006; Yague et al., 2006). Aromatase may also be
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expressed in reactive astrocytes under conditions of cellular
stress in mammalian brains (Azcoitia et al., 2003). In contrast
to mammals, teleosts express two structurally and functionally
different aromatase genes, aromatase A and aromatase B, which
are a result of a gene duplication event (Diotel et al., 2010).
The expression of aromatase B (cyp19a1b) in the teleost brain is
exclusive to one particular cell type, the radial glial cell (RGC)
(Forlano et al., 2001; Diotel et al., 2010; Xing et al., 2014),
which allows direct in vivo study of glial aromatase contributions
without interference from neuronal compartments. Callard et al.
demonstrated for the first time that goldfish exhibit the highest
brain aromatase activity compared to other vertebrates (Callard
et al., 1981). More recently, Diotel et al. have documented the
distribution cyp11a1, 3β-hsd, cyp17, and cyp19a1b mRNAs and
the ability of de novo synthesis of several steroids including
estrone and 17β-estradiol (E2) in the adult zebrafish brain (Diotel
et al., 2011). Although it is very difficult to compare aromatase
activity among species, it is clear that activity in the forebrain of
teleost fish is much higher (100–1000 times) than in birds and
mammals. All these data indicate that teleost fish are excellent
models to study function and regulation of glial aromatase.
Better understanding the regulation of glial aromatase will widen
our knowledge of the control of estrogens in the brain. Local
formation of estrogens are extremely important to maintain the
homeostasis of cell proliferation and cell death, since estrogens in
the brain are proven to be neuroprotective in mammalian brains
and contributing to the generation of new neurons and brain
repair after injury (Azcoitia et al., 2003; Arevalo et al., 2015).
More importantly, recent studies indicate that RGCs are the
progenitors of both neurons and glia during development, and
are the source of new neurons in adult vertebrate brains (Alvarez-
Buylla et al., 2001; Zupanc and Clint, 2003; Pellegrini et al., 2007).
All these lines of evidence suggest that both RGC progenitor
and steroidogenic functions contribute to neurogenesis in adult
vertebrate brains.
Brain aromatization plays numerous important roles
including brain differentiation, neural plasticity, neural
regeneration, neuroendocrine functions, reproductive functions,
and socio-sexual behaviors. It is possible that these processes
are in part regulated by aromatization of androgen and thus
local estrogens formation (Lephart, 1996; Garcia-Segura et al.,
1999, 2003; Azcoitia et al., 2003; Ubuka et al., 2014). There
are many response elements located at the promoter region
of teleost cyp19a1b (Callard et al., 2001; Tchoudakova et al.,
2001), including estrogen response element (ERE) and cyclic
adenosine monophosphate (cAMP) response element (CRE).
Through differential response element recruitment, cyp19a1b
expression can be regulated differently, which suggests there
should be multiple factors implicated in the regulation of
cyp19a1b expression (Kato et al., 1997). It is well known that
estrogens can up-regulate cyp19a1b expression in fish brain,
which is mediated by estrogen receptors (ERs), some of which
act as ligand-activated transcription factors (Belcher and
Zsarnovszky, 2001). Upon binding to classical nuclear ERs,
activated ER homo-dimerizes, and binds to ERE at the promoter
of cyp19a1b, and then mediates transcription (Marlatt et al.,
2008; Strobl-Mazzulla et al., 2008). Due to duplication of the
estrogen receptor beta gene, teleost have three ERs (esr1/ERα,
esr2a/ERβ, and esr2b/ERγ), all of which are expressed in the brain
of fish with an expression pattern similar to that of aromatase
(Forlano et al., 2005; Pellegrini et al., 2005; Strobl-Mazzulla
et al., 2008; Fergus and Bass, 2013). There is evidence showing
that moderate up-regulation of ERα by estrogens precedes
the dramatic up-regulation of aromatase by its own products
(Denslow et al., 2001; Bowman et al., 2002; McEwen, 2002;
Marlatt et al., 2008). The possibility that cyp19a1b expression is
up-regulated by estrogens is intriguing and suggests the presence
of a positive feedback loop within the aromatase and ER-positive
cells, whereby estrogens enhance aromatase expression and
therefore the subsequent products, estrogens.
In addition to estrogenic regulation of the cyp19a1b gene,
our previous neuroanatomical and pharmacological studies
in goldfish reveal that there is a close relationship between
catecholaminergic neurons and aromatase B- and DA D1
receptor (D1R)-positive RGCs in goldfish forebrain (Xing
et al., 2015). Activation of D1R but not D2R up-regulates
cyp19a1b mRNA in cultured RGCs (Xing et al., 2015). The
signaling pathway underlying activated D1R regulation of
cyp19a1b expression involves cAMP, protein kinase A (PKA)
and phosphorylated cAMP response element binding protein
(p-CREB). Whether this regulation involves nuclear ERs has
yet to be characterized. Since it is likely that both mechanisms
are acting simultaneously to affect multifactorial control over
neuroestrogen synthesis, and given the close association between
RGCs and DA neurons we directly tested for interactive effects
on RGCs in vitro.
In this report, we show that both E2 and D1R agonist
SKF 38393 alone significantly increased the expression of
cyp19a1b. Moreover, the expression of cyp19a1b in RGCs may be
synergistically up-regulated or antagonistically down-regulated,
respectively, under low-concentration or high-concentration
exposure to E2 and SKF 38393.
MATERIALS AND METHODS
Ethics Statement
All procedures used were approved by the University of Ottawa
Protocol Review Committee and followed standard Canadian
Council on Animal Care guidelines on the use of animals in
research.
Cell Culture
Common adult female goldfish (Carassius auratus) were
purchased in April from a commercial supplier (Mt. Parnell
Fisheries Inc., Mercersburg, PA, USA) and acclimated for at least
3 weeks prior to experimentation. The fish were maintained
at 18◦C under a natural simulated photoperiod and fed
standard goldfish flakes. Sexually mature, pre-spawning female
goldfish (20–35 g) were anesthetized using 3-aminobenzoic acid
ethyl ester (MS222) for all handling, injection, and dissection
procedures.
Cell culture methods have been established and validated
previously by Xing et al. (2015). Briefly, female goldfish
hypothalamus and telencephalon were dissected and rinsed
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with Hanks Balanced Salt Solution (HBSS; 400mg KCl, 600mg
KH2PO4, 350mg NaHCO3, 8 g NaCl, 48mg Na2HPO4, and
1 g D-Glucose in 1 L ddH2O) with Antibiotic-Antimycotic
solution (Gibco) and minced into small explants. Radial glial
cells were dissociated with trypsin (0.25%, Gibco) and cultured
in Leibovitz’s L-15 medium with 15% Fetal Bovine Serum (FBS)
and Antibiotic-Antimycotic solution. Cell culture medium was
changed 4–7 days after isolation to remove tissue explants
and suspended cells. Following the initial media change, cells
received fresh media once a week until they were ready for their
next passage. RGCs were sub-cultured following trypsinization
(0.125%) for three passages and then used for experiments.
Drugs and Exposures
Cells were exposed to E2 (Sigma-Aldrich) and selective DA
D1R agonist SKF 38393 (Tocris) for 24 h to study their effects
on cyp19a1b, esr1, esr2a, esr2b, and drd1a mRNA and p-CREB
protein level. To investigate ERs involvement in cyp19a1bmRNA
regulation by E2 and SKF 38393, cells were pre-exposed to
estrogen receptor antagonist MPP (Tocris) for 1 h, and then
exposed to E2 or SKF 38393 for 24 h.
RNA Extraction, Quality Control and cDNA
Synthesis
RNA was isolated using the RNeasy Micro kit (Qiagen) as
described in the manufacturer’s protocol. Upon purification,
concentration and quality of all samples were assessed using
the NanoDrop ND-1000 spectrophotometer (Thermo Scientific)
and the 2100 Bioanalyzer (Agilent). RNA integrity values of
samples were above the recommended minimum value of 5 for
quantitative real-time RT PCR applications and ranged from 8.5
to 9.8 (Fleige and Pfaﬄ, 2006). Total cDNA was prepared using
Maxima First Strand cDNA Synthesis Kit for RT-qPCR (Thermo
Scientific). Each 20µl reaction was diluted 10-fold in nuclease-
free water and used as the template for the real-time RT-PCR
assays.
Quantitative Real-Time RT-PCR
Quantitative real-time RT-PCR (qPCR) assays based on SYBR
green detection were used to validate relative gene expression.
Primers used in this study were designed using the Primer3
(http://primer3.sourceforge.net/) software and synthesized by
Invitrogen (Table 1). The Maxima SYBR green qPCR Master
Mix (Thermo Scientific) and CFX96 Real-Time PCR Detection
System (Bio-Rad) were used to amplify and detect the transcripts
of interest. Thermal cycling conditions included a denaturation
step at 95◦C for 3min, and then 40 cycles of denaturation at
95◦C for 10 s, annealing at 60◦C for 30 s followed by melt curve
analysis to confirm product specificity for all transcripts. Serial
1/2 dilution of the pool of all cDNA samples was analyzed to
build the standard curves, from which the mRNA abundance
in samples was calculated using the CFX Manager™ Software
package (Bio-Rad). The efficiencies for all standard curves were
between 92 and 106%. Data were normalized by using NORMA-
GENE algorithm (Heckmann et al., 2011) and then presented as
means+ SEM of fold change to control group (n = 4; assayed in
duplicate).
Droplet Digital PCR
The low expression of D1R (drd1a) in RGC cultures is not
quantifiable using qPCR, so we used a more sensitive method
to measure drd1a mRNA level. Droplet digital PCR (ddPCR)
was performed using 25 ng of each cDNA sample and QX200™
ddPCR™ EvaGreen Supermix by employing QX200™ Droplet
Digital™ PCR System (Bio-Rad). The ddPCR conditions were
as follows: an initial denaturation for 5min at 95◦C followed
by 40 cycles of denaturation for 30 s at 95◦C and annealing and
extension for 1min at 56◦C, then signal stabilization for 5min
at 4◦C and 5min at 90◦C. Template DNA was omitted from the
ddPCR reaction as a no template control (NTC) and the results of
ddPCR were analyzed using the QuantaSoft Software (Bio-Rad).
The absolute copy number of targeted gene was divided by the
average of the absolute copy number of two reference genes β-
actin and 18s, and presented as means + SEM of fold change to
control group (n = 4; assayed in duplicate).
Western Blot
Total protein extract from RGCs was denatured and separated
by electrophoresis on a 10% SDS–polyacrylamide gel and
transferred to a PVDF membrane as described previously by
Zhao et al. (2006). Membranes were incubated with anti-
Phospho-CREB (Ser133, Cell signaling technology, 9198S)
antibodies overnight at 4◦C and then incubated with donkey
anti-rabbit IgG antibody (GE Health Care, NA934VS). Blots
were visualized using the Amersham ECL Prime Western
Blotting Detection System (GE Health Care, RPN2232). Images
were obtained using a ChemiDoc XRS+ system (Bio-Rad) and
analyzed with image lab (Bio-Rad). Same blot incubated with
anti-Phospho-CREB antibodies before was stripped and re-
probed with primary anti-actin (Cedarlane, CLT9001) antibodies
overnight at 4◦C and then incubated with goat anti-mouse IgG-
HRP (Santa Cruz, sc-2005), where actin served as an internal
control.
Statistics
In all cases and before any analysis, normality and homogeneity
of variances was verified using Shapiro-Wilk’s and Levene’s test,
respectively. Comparison of two groups was performed using
Student’s t-test in GraphPad Prism (Version 6.0). Two-way
analysis of variance (ANOVA) followed by Tukey’s post-hoc test
in GraphPad Prism (Version 6.0) was used to determine the
effects of single or combined drug treatments. P = 0.05 were
considered statistically significant. Data were presented as mean
+ SEM. Note that the t- and F-statistics, degrees of freedom (df)
of interaction (DFn), the total degrees of freedom (DFd), and P-
values are reported in the Results Section. The P-values associated
with main effects and the interactions are reported directly on the
graphs.
RESULTS
Regulation of cyp19a1b and ER Expression
by SKF 38393 and E2
Here, the qPCR data show that 10µM SKF 38393 was able to
increase the expression of cyp19a1b (t = 2.454, df = 6, P =
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TABLE 1 | Primer sets used for qPCR and ddPCR.
Gene Primer sequence (Forward) Primer sequence (Reverse) Amplicon size Accession no.
β-actin CTGGGATGATATGGAGAAGA CCAGTAGTACGACCTGAAGC 215 AB039726
18s AAACGGCTACCACATCCAAG CACCAGATTTGCCCTCCA 165 AF047349
cyp19a1b TGCTGACATAAGGGCAATGA GGAAGTAAAATGGGTTGTGGA 153 AB009335
esr1 GCAGGAGGGTTTGATTCTGAGA CCATAATGATAGCCGGACGCA 76 AY055725
esr2a TGACTACATCTGCCCTGCCA CCAACTTCGTAACATTTTCGGAGA 72 AF061269
esr2b TGGTCCCTTTAAATTCAGCAATCT GTGTTTCCCTGTAGGCCAGTG 95 AF177465
drd1a CCCTTTGGTGCGTTTTGT GAGCCTTGTGCCATTTGAG 210 L08602
0.0225), but not esr1 (t = 1.744, df = 6, P = 0.0952), esr2a
(t = 1.338, df = 6, P = 0.1947), and esr2b (t = 1.638, df =
22, P = 0.1157) after 24 h incubation (Figure 1A). The 100 nM
concentration of E2 did not affect cyp19a1b (t = 1.557, df =
6, P = 0.1705), esr1 (t = 0.5747, df= 6, P = 0.5864), esr2a
(t = 0.5106, df= 6, P = 0.6993), and esr2b (t = 0.9012,
df= 6, P = 0.4022) mRNAs after 24 h incubation (Figure 1B).
However, when the concentration of E2 was increased to 1µM,
the expression of cyp19a1b (t = 4.791, df = 6, P = 0.003) and
esr2b (t = 10.65, df= 6, P < 0.0001) were increased dramatically
6.7-fold and 2.9-fold, respectively, but not esr1 (t = 0.3295,
df= 6, P = 0.7530) and esr2a (t = 0.2395, df = 6, P = 0.779;
Figure 1C). These data suggest the up-regulation of esr2b may
contribute to the stimulatory effect of E2 in cyp19a1b expression.
The Involvement of ERs in cyp19a1b
Regulation by E2 and SKF 38393
When RGC cultures are exposed to SKF38393 and E2 for 24 h
there is no change in the expression of esr1 and esr2a. This result
led us to investigate the possible contribution of pre-existing ERs
in RGCs to cyp19a1b up-regulation. The ERα and ERβ antagonist
MPP was administered to RGC culture 1 h before SKF 38393 and
E2. Data revealed that MPP alone decreases the expression of all
three ERs (t = 2.462, df = 6, P = 0.049; t = 2.285, df = 6,
P = 0.0624; t = 3.134, df= 6, P = 0.0202, respectively) by 29.9–
57.6% (Figure 2A), but has no effect on cyp19a1b (F = 32.65,
DFn= 1, DFd= 12, P = 0.8582; F = 18.15, DFn= 1, DFd= 12,
P = 0.3065, respectively) expression (Figures 2B,C). Two-way
ANOVAs were conducted that examined the effect of MPP and
SKF 38393 as well as MPP and E2 on cyp19a1b expression. There
was a statistically significant interaction between MPP and SKF
38393 (F = 32.65, DFn= 1, DFd= 12, P < 0.0001), and between
MPP and E2 (F = 18.15, DFn = 1, DFd = 12, P = 0.0011).
The stimulatory effect of SKF 38393 (F = 32.65, DFn = 1, DFd
= 12, P = 0.0002) and E2 (F = 18.15, DFn = 1, DFd = 12,
P < 0.0001) on cyp19a1bmRNAwas completely blocked byMPP
(Figures 2B,C).
The Combined Effects of E2 and SKF 38393
on cyp19a1b Regulation
Based on the previous dose-dependent studies (Xing et al., 2015
and unpublished data), we examined the combined effects of two
concentrations of SKF 38393 and E2. Our results indicate that
there is either a synergistic or antagonistic effect in cyp19a1b
FIGURE 1 | Effects of SKF 38393 and E2 on the expression of
cyp19a1b, esr1, esr2a, and esr2b in primary RGC culture. Quantitative
real-time PCR analysis showing variations in the relative amounts of the
cyp19a1b, esr1, esr2a, and esr2b mRNAs in primary RGCs culture exposed
to 10µM SKF38393 (A) 100 nM E2 (B) and 1µM E2 (C). Data were
normalized and defined as fold change relative to control, and bars represent
the mean + SEM. Treatment groups marked by asterisks have significantly
different mRNA levels compared to control (P < 0.05).
regulation by E2 and SKF 38393, which is dependent on the
concentration of E2. Two-way ANOVAs were conducted that
examined the effect of SKF 38393 and E2 on cyp19a1b expression.
As shown in Figure 3A, the low concentration of E2 (100 nM)
alone increased cyp19a1b expression 1.5 fold, but this was not
statistically significant (F = 0.1071, DFn = 1, DFd = 12, P =
0.1498) regardless of the combination with SKF 38393 (1µM).
In contrast, the high concentration of E2 (1µM) alone increased
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FIGURE 2 | Effects of MPP on the expression of esr1, esr2a, and esr2b
and the regulation of cyp19a1b expression by DA and E2 in primary
RGC culture. Quantitative real-time PCR analysis showing variations in the
relative amounts of the cyp19a1b, esr1, esr2a, and esr2b mRNAs in primary
RGCs culture exposed to 100 nM MPP (A), 100 nM MPP and 10µM SKF
38393 (B), 100 nM MPP and 1µM E2 (C). Data were normalized and defined
as fold change relative to control, and bars represent the mean + SEM.
Treatment groups marked by an asterisk (A) are significantly different from
controls (P < 0.05). Treatment groups marked with different letters (B,C) are
significantly different (P < 0.05).
cyp19a1b 6.7-fold (F = 0.2028, DFn= 1, DFd= 12, P = 0.0002,
Figure 3B) significantly regardless of the combination with SKF
38393 (1µM). There was no statistically significant interaction
between SKF 38393 (1µM) and either the low (100 nM; F =
0.1071, DFn = 1, DFd = 12, P = 0.7491, Figure 3A) or higher
(1µM; F = 0.2028, DFn= 1, DFd= 12, P = 0.6601, Figure 3B)
concentration of E2. When the concentration of SKF 38393 was
increased to 10µM, statistically significant interactions between
SKF 38393 and both low concentration (F = 8.112, DFn = 1,
DFd = 12, P = 0.0147, Figure 3C) and high concentration of
E2 (F = 14.91, DFn = 1, DFd = 12, P = 0.0023, Figure 3D)
were evident. The Two-way ANOVA indicates that both 10µM
SKF 38393 and 100 nM E2 increased cyp19a1b expression
2.8-fold and 1.5-fold, consistent with the earlier experiment
shown in Figures 1A,B, respectively. Post-hoc tests showed that
the combination of high concentration of SKF 38393 and
low concentration of E2 synergistically up-regulated cyp19a1b
(F = 8.112, DFn= 1, DFd= 12, P = 0.0003, Figure 3C)
expression 8.0-fold. Contrasting this is the experiment where
high concentration of SKF 38393 and high concentration of
E2 were used. Exposure of RGCs to 1µM E2 alone increased
cyp19a1b expression 6.7-fold, and the high concentration of SKF
38393 inhibited this effect (F = 14.91, DFn= 1, DFd = 12,
P = 0.0141, Figure 3D).
Synergistic Effects of Low Levels of E2 on
SKF 38393-Induced cyp19a1b Expression
are Associated with Parallel Increases in
p-CREB
To further understand the underlying mechanisms of synergistic
up-regulation of cyp19a1b by low concentration of E2 and high
concentration of SKF 38393, we studied two components of the
D1R/cAMP/PKA/p-CREB pathway, drd1a in mRNA level and
p-CREB in protein level as well as the expression of esr1, esr2a,
and esr2b. Two-way ANOVAs were conducted that examined the
effect of SKF 38393 and E2 on drd1a, esr1 esr2a, and esr2bmRNA
level and p-CREB protein level in cultured RGCs. There was a
statistically significant interaction (F = 7.393, DFn = 1, DFd =
12, P = 0.01786) between SKF 38393 and E2 for drd1a mRNA.
Post-hoc tests showed that the combination of SKF 38393 and E2
up-regulated drd1a mRNA (F = 7.393, DFn = 1, DFd = 12,
P = 0.0029; Figure 4A), although increases were not very large,
in the range of 1.7 fold. There was also a statistically significant
interaction (F = 10.35, DFn= 1, DFd= 12, P = 0.0123) between
SKF 38393 and E2 for p-CREB protein level (Figures 4B–D). The
D1R agonist SKF 38393 alone increased p-CREB 2.2-fold, and
this was enhanced to 3.5-fold in the presence of E2, paralleling
these results for cyp19a1b mRNA (Figure 3C). No effects on the
expression of esr1, esr2a and esr2b (F = 0.2907, DFn= 1, DFd=
12, P = 0.5996; F = 0.0061, DFn = 1, DFd = 12, P = 0.9389;
F = 0.0078, DFn = 1, DFd = 12, P = 0.9312, respectively) were
observed for the E2 and SKF 38393 treatments (Figure 5).
Antagonistic Effects of High Levels of E2
on SKF 38393-Induced cyp19a1b
Expression are Associated with Parallel
Decreases in p-CREB Protein and esr2b
mRNA
Further analysis was essential in understanding the potential
mechanisms of antagonistic regulation of cyp19a1b by the
combined high concentration of E2 and high concentration of
SKF 38393. As with the previous experiment, two-way ANOVAs
were conducted that examined the potential interactive effects of
SKF 38393 and E2 on drd1a, esr1 esr2a, and esr2b mRNA level
and p-CREB protein level. Exposure to 10µM SKF 38393 and
1µME2 alone did not affect drd1a (F = 0.9571, DFn= 1, DFd=
12, P = 0.3472) mRNA levels in cultured RGCs (Figure 6A). In
contrast, there was a statistically significant interaction between
SKF 38393 and E2 on p-CREB protein (F = 6.252, DFn = 1,
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FIGURE 3 | Quantitative real-time PCR analysis showing variations in the relative amounts of the cyp19a1bmRNA in primary RGCs culture exposed to
100nM E2 and 1 µM SKF 38393 (A) 1 µM E2 and 1 µM SKF 38393 (B) 100nM E2 and 10 µM SKF 38393 (C) 1 µM E2 and 10 µM SKF 38393 (D). Data were
normalized and defined as fold change relative to control, and bars represent the mean + SEM. Treatment groups marked by different letters are significantly different
(P < 0.05).
DFd = 12, P = 0.0369) and esr2b mRNA (F = 86.01, DFn
= 1, DFd = 12, P < 0.0001) levels. Post-hoc tests showed that
higher concentration of E2 inhibited the up-regulation of p-
CREB protein induced by SKF 38393 (F = 6.252, DFn = 1,
DFd = 12, P = 0.0484; Figures 6B–D) and that SKF 38393
inhibited the up-regulation of esr2b mRNA induced by higher
concentration of E2 (F = 86.01, DFn= 1, DFd= 12, P < 0.0001;
Figure 7C) in RGCs, both following a similar pattern to that of
cyp19a1b expression (Figure 3D). No effects on esr1 and esr2a
were evident (Figures 7A,B).
DISCUSSION
The findings of this study indicate that cyp19a1b expression is
up-regulated in goldfish RGC cultures in response to individual
treatments with E2 or D1R agonist. However, co-exposure to
these substances leads to either a further up-regulation or a
down-regulation of cyp19a1b mRNA levels that are dependent
on the concentration of E2. This is the first evidence for direct
multifactorial control of aromatase in RGCs from the adult
teleost brain. In mammals, aromatase is expressed in both
neurons and glia (Tsuruo et al., 1995; Azcoitia et al., 2003).
In contrast, RGCs are the exclusive cells to express aromatase
in teleost brains (Forlano et al., 2001; Tong et al., 2009). This
makes teleosts amenable models to delineate direct control of
glial aromatase expression. Our data provides the foundation for
further analysis of neurotransmitter and estrogenic regulation
of RGCs, and contributes to our understanding of neuronal-
glial interactions. This is important because estrogens in the
CNS control fundamental processes such as sexual behavior
and neurogenesis (Okada et al., 2008; Ubuka and Tsutsui, 2014;
Pellegrini et al., 2015).
The ability of E2 to regulate brain aromatase mRNA has
been reported for a variety of species, including fish, birds, and
rats (Hutchison and Steimer, 1986; Pellegrini et al., 2005; Zhao
et al., 2007; Strobl-Mazzulla et al., 2008). Here, we confirm and
extend these observations because we show a direct effects of
E2 on isolated goldfish RGCs. Our pharmacological experiments
using goldfish RGCs in culture indicate the involvement of ERs
since the up-regulation of cyp19a1b caused by exogenous E2 was
completely blocked by the ER antagonistMPP (Pinto et al., 2014),
consistent with previous findings in zebrafish in vivo (Diotel et al.,
2010). Here, we report that E2 in vitro can increase esr2bmRNA
only at a relatively high concentration. Contrary to in vivo reports
in teleost, we did not find effects of exogenous E2 on esr1 and
esr2a expression in RGC cultures (Menuet et al., 2005; Marlatt
et al., 2008). To further understand the involvement of ERs, we
administrated MPP together with SKF 38393 and E2. Exposure
to MPP decreased the expression of all three nuclear ERs,
suggesting that endogenous estrogen may be involved. Moreover,
MPP blocked the stimulatory effect of added E2 on cyp19a1b
expression. This finding indicates that the up-regulation of
cyp19a1b mRNA by E2 is potentially due to the recruitment of
the existing esr1 and esr2a and/or increasing expression of esr2b
to contribute to the positive feedback loop between aromatase,
estrogens, and ERs (Diotel et al., 2010). Further studies on the
involvement of esr2b are currently limited by the lack of a
selective esr2b antagonist, although we do hypothesize that esr2b
may be contributing to the up-regulation of cyp19a1b in RGCs,
given the potency of esr2b to drive reporter gene expression for a
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FIGURE 4 | Synergistic up-regulation of D1R and p-CREB by E2 and
SKF 38393. Droplet digital PCR analysis showing variations in the absolute
amounts of the drd1a mRNA in primary RGCs culture exposed to 100 nM E2
and 10µM SKF38393 (A). Western blot showing variations in the relative
protein level of p-CREB in primary RGCs culture exposed to 100 nM E2 and
10µM SKF 38393. Western blot image (B) showing the p-CREB
immunoreactivity in control (lane 1), 100 nM E2 treated (lane 2), 10µM SKF
38393 treated (lane3), and both 100 nM and 10µM SKF 38393 treated (lane 4)
groups, where actin served as internal control (C). The densitometric analysis
of western blot is reported as an arbitrary value relative to the average of all
bands on the same blot. Data were normalized and defined as fold change
relative to control, and bars represent the mean + SEM (n = 4, D). Treatment
groups marked by different letters are significantly different (P < 0.05).
consensus ERE construct or for the zebrafish cyp19a1b promoter
construct in transfected cell assays (Menuet et al., 2002). It is
unlikely that the G-protein coupled membrane estrogen receptor
(GPER) is involved because we have been unable to identify
GPER in RGCs using targeted PCR and RNA sequencing (data
not shown).
We confirm here the results from our recent study (Xing
et al., 2015) of the direct stimulatory effect of D1R activation
of the p-CREB signaling pathway to increase the expression of
cyp19a1b in adult female goldfish RGCs. Interestingly, in the
current study, pretreatment with the estrogen antagonist MPP
completely blocks SKF 38393-stimulated cyp19a1b expression.
This suggests that DA does not increase the expression of ERs
but somehow activates or recruits the pre-existing ERs that
contribute to the increase in expression of cyp19a1b.
While it is clear from our data that treatments with E2
or SKF 38393 alone can increase expression of cyp19a1b, this
is unlikely to represent situations in vivo where RGCs would
FIGURE 5 | Quantitative real-time PCR analysis showing variations in
the relative amounts of the esr1 (A), esr2a (B) and esr2b mRNA (C) in
primary RGC cultures exposed to 100nM E2 and 10 µM SKF 38393.
Data were normalized and defined as fold change relative to control, and bars
represent the mean + SEM. There were no statistically signficant treatment
effects.
be responding to neurotransmitters and endogenous estrogens
simultaneously. Therefore, we treated RGCs with combinations
of low and high concentrations of the D1R agonists SKF 38393
and low and high concentrations of E2. It is evident that the
RGC cyp19a1b response to D1R activation is dependent on
the level of E2. The maximal response in cyp19a1b expression
(i.e., 8.0-fold) was obtained from RGCs exposed to the lower
E2 level of 100 nM plus the concentration of 10µM SKF
38393, which we showed previously to be the highest effective
concentration in the culture system (Xing et al., 2015). These
experiments revealed a synergistic interaction between E2 and
SKF 38393 that was supported statistically. Additionally, the
levels of cellular p-CREB most closely followed the pattern of
cyp19a1b expression, however, amore complex effect onD1R and
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FIGURE 6 | Antagonistic regulation of D1R and p-CREB by E2 and SKF
38393. Droplet digital PCR analysis showing variations in the absolute
amounts of the d1r mRNA in primary RGCs culture exposed to 1µM E2 and
10µM SKF 38393 (A). Western blot image (B) showing the p-CREB
immunoreactivity in control (lane 1), 1µM E2 treated (lane 2), 10µM SKF
38393 treated (lane3), and both 1µM and 10µM SKF 38393 treated (lane 4)
groups, where actin served as internal control (C). The densitometric analysis
of western blot is reported as an arbitrary value relative to the average of all
bands on the same blot. Data were normalized and defined as fold change
relative to control, and bars represent the mean + SEM (n = 4, D). Treatment
groups marked by different letters are significantly different (P < 0.05).
ER expression was evident. The low level E2 treatment appears
to amplify signaling via D1R/cAMP/PKA/p-CREB. Our absolute
quantification of drd1a mRNA abundance showed that the low
concentration of E2 increased D1R gene expression, especially in
the presence of the D1R agonist SKF 38393. With the increased
expression level of D1R, we hypothesized the activity of the
downstream signal transduction pathway will be higher than
the control level. Our data showed that the protein level of p-
CREB also increased upon exposure to E2 and SKF 38393, similar
to the drd1a expression pattern. It is well-known that nuclear
ERs bind to EREs thereby enhancing cyp19a1b transcription
(Callard et al., 2001; Menuet et al., 2002, 2005) as transcription
factors themselves or potentially through interactions with other
transcription factors, such as activator protein 1 (Marino et al.,
2006; Zhang and Trudeau, 2006). While our experiments with
the ER antagonist MPP indicate that endogenous pre-existing
ERs are involved, our findings do not support that an increase in
FIGURE 7 | Quantitative real-time PCR analysis showing variations in
the relative amounts of the esr1 (A), esr2a (B) and esr2b mRNA (C) in
primary RGCs culture exposed to 1 µM E2 and 10 µM SKF 38393. Data
were normalized and defined as fold change relative to control, and bars
represent the mean + SEM. Treatment groups marked by different letters are
significantly different (P < 0.05).
ERs is required for the synergistic up-regulation of cyp19a1b by
E2 and SKF 38393 in RGCs since no increase in expression was
observed for any of the three nuclear ERs. Together these data
indicate that the up-regulation of drd1a expression and p-CREB
protein may contribute to the overall synergistic effects of the low
concentration of E2 and SKF 38393 on cyp19a1b expression.
While we do not have an estimate of the intracellular or
extracellular levels of estrogens at or near regions of high RGC
density in the brain, we consider the high 1µM concentration of
E2 to be supraphysiological and the low 100 nM concentration
to be physiological relative to circulating E2 (Kobayashi et al.,
1988) based on previous in vivo responses to exogenous estrogens
in goldfish (Martyniuk et al., 2006). Nevertheless, we originally
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hypothesized that the higher combined concentrations of E2 and
SKF 38393 would cause up-regulation of cyp19a1b expression.
However, co-treatment with 10µM SKF 38393 significantly
reduced the high cyp19a1b expression induced by 1µM E2. This
was evident at the level of intracellular signaling because p-CREB
protein levels were also reduced by the co-treatment of high
concentration of E2 and high concentration of SKF 38393. The
effects of E2 on CREB are variable since both inhibition and
stimulation have been reported, perhaps reflecting tissue-specific
regulation (Duan et al., 1999; Choi et al., 2004). Our findings did
not show any change in p-CREB protein levels after exposure to
E2 alone regardless of the concentration. Moreover, 10µM SKF
38393 reduced the increase in esr2b expression caused by the high
1µM concentration of E2 in our RGCs. Even though SKF 38393
did not cause any down-regulation after 24 h exposure, time-
course studies have shown that esr2b decreased after 8 h exposure
to SKF 38393 alone in RGC culture (unpublished data). Although
speculative, together these data indicate that the attenuation of p-
CREB protein and esr2b expression may contribute to the overall
antagonistic effects of the high concentrations of E2 and SKF
38393 on cyp19a1b expression.
In summary, we have described an example of complex
control of aromatase B expression in adult teleost RGCs.
Anatomical and physiological data (Xing et al., 2015) indicate
a close relationship between catecholaminergic cell bodies
and fibers and D1R-expressing RGCs in female goldfish
brain. Pharmacological activation of D1R up-regulates cyp19a1b
expression in RGCs, which ultimately would increase estrogen
synthesis. It has been previously shown and confirmed here,
that teleost RGCs respond positively to E2 with an increase
in cyp19a1b expression. We extend these observations to
demonstrate a potentiating or synergistic interaction between
dopaminergic and estrogenic stimulation of cyp19a1b expression.
On the other hand, it appears that overstimulation of RGCs with
the combined high concentration of E2 and high concentration
of SKF 38393 may limit cyp19a1b expression, and thus reduce
estrogen synthesis in a manner similar to classical negative
feedback control (Figure 8). In the teleost brain, the two main
roles of estrogens in the adult brain that have been documented
thus far are regulation of expression of neuroendocrine-
related genes (Martyniuk et al., 2006), and the inhibition of
neurogenesis (Diotel et al., 2013; Makantasi and Dermon, 2014).
Interactive regulation of aromatase B by dopamine and estrogens
therefore, would finely regulate local estrogen levels that in
turn could regulate adjacent RGCs that express nuclear ERs,
or neurons in the vicinity that express these receptors or
GPER. However, further studies on the conversion of androgen
precursors by aromatase B are needed to further understand
the control of estrogen synthesis in the brain. Given the array
of neurotransmitter and neuropeptide-expressing neurons and
fibers in the neurogenic regions where cyp19a1b expressing
RGCs are found, it is likely that many other neurohormones
regulate the steroidogenic function of this critical cell. The culture
system we have developed provides an amenable approach to the
understanding of multifactorial control of RGCs.
FIGURE 8 | Proposed mechanisms underlying the synergistic and
antagonistic regulation of cyp19a1b expression in cultured RGCs.
Activation of the D1R by SKF 38393 (10µM) up-regulates cyp19a1b
expression, most likely through cAMP, PKA, and the phosphorylation of CREB.
This up-regulation can be enhanced by low concentration of E2 (100 nM)
through increasing the expression of D1R and the level of p-CREB protein
(pink arrows). Also, up-regulation of cyp19a1b expression by E2 and DA both
requires the involvement of esr1 and esr2a. However, a high concentration of
E2 (1µM) and SKF38393 (10µM) together failed to up-regulate cyp19a1b
expression, potentially due to attenuation of esr2b expression and p-CREB
levels (purple bulbous arrows). RGC, radial glial cells; DA, dopamine; D1R,
dopamine D1 receptor; cAMP, cyclic adenosine monophosphate; PKA, protein
kinase A; CREB, cAMP response element binding protein; p-CREB,
phosphorylated cAMP response element binding protein; CRE, cAMP
response element; E2, 17β-estradiol; ERs, estrogen receptors; ERE, estrogen
response element.
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